Chris Torrance
Advisory Board
GeoPlus
Liechtenstein
Biography
Chris is an innovative R&D leader and a seasoned biotech entrepreneur. His principal expertise lies in oncology and drug discovery. Chris pioneered the use of isogenic cancer cell models in high-throughput drug screening. In 2007, He founded Horizon Discovery, a translational genomics company which supplies genetically edited cell lines for research into personalised medicine.
Research Interest
biotechnology